UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1327) 1327
science & technology (1122) 1122
life sciences & biomedicine (1010) 1010
glioblastoma - enzymology (1006) 1006
brain neoplasms - enzymology (706) 706
oncology (615) 615
glioblastoma - pathology (610) 610
glioblastoma (573) 573
cell line, tumor (539) 539
animals (519) 519
brain neoplasms - pathology (433) 433
glioblastoma multiforme (414) 414
glioblastoma - genetics (374) 374
female (332) 332
mice (307) 307
male (301) 301
glioblastoma - drug therapy (299) 299
brain neoplasms - genetics (258) 258
cell biology (252) 252
cancer (231) 231
middle aged (217) 217
glioblastoma - metabolism (208) 208
adult (200) 200
neurosciences & neurology (198) 198
apoptosis (196) 196
brain neoplasms - drug therapy (194) 194
tumor cells, cultured (190) 190
biochemistry & molecular biology (189) 189
tumors (177) 177
glioma - enzymology (172) 172
astrocytoma - enzymology (171) 171
aged (170) 170
glioma (170) 170
brain tumors (161) 161
signal transduction (158) 158
gliomas (149) 149
research (148) 148
gene expression regulation, neoplastic (143) 143
mice, nude (141) 141
apoptosis - drug effects (140) 140
phosphorylation (132) 132
immunohistochemistry (131) 131
brain cancer (128) 128
neurosciences (128) 128
proteins (128) 128
transfection (125) 125
clinical neurology (123) 123
antineoplastic agents - pharmacology (119) 119
rats (119) 119
cell proliferation (118) 118
gene expression (118) 118
prognosis (118) 118
cell proliferation - drug effects (116) 116
kinases (115) 115
brain neoplasms - metabolism (113) 113
science & technology - other topics (113) 113
glioblastoma - therapy (109) 109
multidisciplinary sciences (106) 106
neoplasm invasiveness (105) 105
mutation (103) 103
research article (102) 102
genetic aspects (100) 100
medicine (97) 97
signal transduction - drug effects (96) 96
time factors (95) 95
blotting, western (94) 94
enzymes (94) 94
glioma - pathology (93) 93
dacarbazine - analogs & derivatives (89) 89
xenograft model antitumor assays (88) 88
analysis (87) 87
enzyme inhibitors - pharmacology (84) 84
brain neoplasms - therapy (83) 83
health aspects (83) 83
pathology (80) 80
astrocytoma - pathology (78) 78
brain - enzymology (78) 78
physiological aspects (78) 78
science (78) 78
brain (77) 77
care and treatment (76) 76
pharmacology & pharmacy (76) 76
temozolomide (76) 76
cell survival - drug effects (75) 75
dna methylation (73) 73
chemotherapy (71) 71
proto-oncogene proteins c-akt - metabolism (71) 71
cell cycle (70) 70
enzyme activation (70) 70
cell survival (69) 69
genetics & heredity (69) 69
dose-response relationship, drug (68) 68
neurology (68) 68
gene expression regulation, enzymologic (67) 67
development and progression (66) 66
antineoplastic agents - therapeutic use (65) 65
medicine, research & experimental (65) 65
research & experimental medicine (65) 65
biology (64) 64
medicine & public health (63) 63
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1502) 1502
German (19) 19
Japanese (11) 11
French (10) 10
Russian (10) 10
Italian (3) 3
Chinese (2) 2
Norwegian (1) 1
Polish (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 1527-7755, 06/2008, Volume 26, Issue 18, pp. 3015 - 3024
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 13, pp. 2192 - 2197
Purpose Standard therapy for glioblastoma (GBM) is temozolomide (TMZ) administration, initially concurrent with radiotherapy (RT), and subsequently as... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Dacarbazine - adverse effects | Glioblastoma - enzymology | Humans | Middle Aged | Male | Glioblastoma - radiotherapy | Glioblastoma - genetics | Time Factors | Chemotherapy, Adjuvant - adverse effects | Radiotherapy, Adjuvant - adverse effects | Brain Diseases - etiology | Genetic Predisposition to Disease | Tumor Suppressor Proteins - metabolism | DNA Modification Methylases - metabolism | Brain Neoplasms - genetics | Brain Diseases - enzymology | Brain Neoplasms - drug therapy | Radiation Injuries - enzymology | Disease Progression | Radiation Injuries - etiology | Magnetic Resonance Imaging | Glioblastoma - pathology | Radiation Injuries - pathology | Antineoplastic Agents, Alkylating - adverse effects | Glioblastoma - drug therapy | Brain Diseases - genetics | Brain Neoplasms - pathology | DNA Repair Enzymes - genetics | Gene Expression Regulation, Neoplastic | Necrosis | Patient Selection | DNA Methylation | Radiation Injuries - genetics | Tumor Suppressor Proteins - genetics | DNA Repair Enzymes - metabolism | Dacarbazine - analogs & derivatives | Adult | Female | Retrospective Studies | Brain Neoplasms - radiotherapy | Promoter Regions, Genetic | Brain Neoplasms - enzymology | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Gene Expression Regulation, Enzymologic | DNA Modification Methylases - genetics | Brain Diseases - pathology | Aged | Index Medicus
Journal Article
Stem cells (Dayton, Ohio), ISSN 1549-4918, 2009, Volume 28, Issue 1, pp. 5 - N/A
Cancer stem cells (CSCs) are thought to be critical for the engraftment and long‐term growth of many tumors, including glioblastoma (GBM). The cells are at... 
NOTCH | γ‐Secretase inhibitor | Cancer Stem Cell | Glioblastoma | Cancer stem cell | γ-Secretase inhibitor | Cell & Tissue Engineering | Life Sciences & Biomedicine | Hematology | Oncology | Biotechnology & Applied Microbiology | Science & Technology | Cell Biology | Neurons - pathology | Glioblastoma - enzymology | Phosphorylation | Apoptosis - drug effects | Neoplastic Stem Cells - drug effects | Humans | Brain Neoplasms - pathology | Glycoproteins - metabolism | Neoplastic Stem Cells - immunology | Receptor, Notch2 - genetics | Antigens, CD - metabolism | Dose-Response Relationship, Drug | Brain Neoplasms - immunology | Peptides - metabolism | Transfection | Time Factors | Biomarkers, Tumor - metabolism | Neoplastic Stem Cells - pathology | Female | Antineoplastic Agents - pharmacology | Tumor Cells, Cultured | Neurons - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Spheroids, Cellular | STAT3 Transcription Factor - metabolism | Brain Neoplasms - enzymology | Enzyme Inhibitors - pharmacology | Neurons - immunology | Receptor, Notch2 - metabolism | Tumor Burden | Brain Neoplasms - drug therapy | AC133 Antigen | Xenograft Model Antitumor Assays | Amyloid Precursor Protein Secretases - metabolism | Animals | Glioblastoma - immunology | Signal Transduction - drug effects | Mice, Nude | Glioblastoma - pathology | Neurons - enzymology | Cell Proliferation - drug effects | Mice | Amyloid Precursor Protein Secretases - antagonists & inhibitors | Glioblastoma - drug therapy | Neoplastic Stem Cells - enzymology | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 05/2013, Volume 110, Issue 21, pp. 8644 - 8649
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/1999, Volume 5, Issue 5, pp. 1107 - 1113
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 06/2010, Volume 28, Issue 17, pp. 2817 - 2823
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 11/2009, Volume 8, Issue 11, pp. 3024 - 3035
Rhabdomyosarcoma, consisting of alveolar (aRMS) and embryonal (eRMS) subtypes, is the most common type of sarcoma in children. Currently, there are no targeted... 
polo-like kinase 1 | siRNA library | kinases | rhabdomyosarcoma | phosphatases | Life Sciences & Biomedicine | Oncology | Science & Technology | Protein Kinases - metabolism | RNA, Small Interfering - genetics | Glioblastoma - enzymology | Protein Kinases - genetics | Bone Neoplasms - therapy | Sarcoma, Ewing - therapy | Humans | Neuroblastoma - enzymology | Child, Preschool | Rhabdomyosarcoma - pathology | Apoptosis - genetics | Immunoblotting | Neuroblastoma - therapy | Cell Cycle Proteins - antagonists & inhibitors | Transfection | Glioblastoma - genetics | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Cycle Proteins - genetics | Bone Neoplasms - genetics | Cell Growth Processes - genetics | Child | Protein-Serine-Threonine Kinases - metabolism | Phosphoric Monoester Hydrolases - antagonists & inhibitors | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Phosphoric Monoester Hydrolases - genetics | Bone Neoplasms - enzymology | Osteosarcoma - enzymology | Neuroblastoma - genetics | Cell Cycle Proteins - metabolism | Gene Silencing | Protein-Serine-Threonine Kinases - genetics | Proto-Oncogene Proteins - genetics | Glioblastoma - therapy | Rhabdomyosarcoma - enzymology | Animals | Cell Line, Tumor | Mice | Rhabdomyosarcoma - genetics | Osteosarcoma - genetics | Phosphoric Monoester Hydrolases - metabolism | RNA, Small Interfering - administration & dosage | Sarcoma, Ewing - genetics | Osteosarcoma - therapy | Rhabdomyosarcoma - therapy | Sarcoma, Ewing - enzymology | Genetic Therapy - methods | Index Medicus
Journal Article
Molecular cell, ISSN 1097-2765, 03/2017, Volume 65, Issue 5, pp. 917 - 931.e6
Journal Article
Molecular cell, ISSN 1097-2765, 06/2017, Volume 66, Issue 5, pp. 684 - 697.e9
Overcoming metabolic stress is a critical step in tumor growth. Acetyl coenzyme A (acetyl-CoA) generated from glucose and acetate uptake is important for... 
ACSS2 | lysosomal biogenesis | autophagy | TFEB | nucleus | AMPK | acetyl-CoA | tumor development | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | alpha Karyopherins - metabolism | AMP-Activated Protein Kinases - metabolism | Glioblastoma - enzymology | Phosphorylation | Humans | Brain Neoplasms - pathology | Gene Expression Regulation, Neoplastic | Stress, Physiological | Male | Autophagy | Cell Nucleus - enzymology | Organelle Biogenesis | Lysosomes - metabolism | Transfection | Glioblastoma - genetics | RNA Interference | Acetate-CoA Ligase - genetics | Cell Nucleus - pathology | Transcription, Genetic | Acetylation | Active Transport, Cell Nucleus | Binding Sites | Promoter Regions, Genetic | Brain Neoplasms - enzymology | Cell Survival | Brain Neoplasms - genetics | Acetyl Coenzyme A - metabolism | Animals | Energy Metabolism | Acetate-CoA Ligase - metabolism | Mice, Nude | Glioblastoma - pathology | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - genetics | alpha Karyopherins - genetics | Cell Line, Tumor | Protein Binding | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - metabolism | Mice, Inbred BALB C | Protein Processing, Post-Translational | Histones - metabolism | Medical colleges | Thiols | Brain tumors | Genes | Genetic transcription | Glucose | Dextrose | Gliomas | Ligases | Stem cells | Medical genetics | Genetic aspects | Protein kinases | Resveratrol | Development and progression | Index Medicus
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 12/2009, Volume 69, Issue 24, pp. 9157 - 9159
Mutations of the isocitrate dehydrogenase (IDH) metabolic enzymes IDH1 and IDH2 have been found to be frequent and early genetic alterations in astrocytomas... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Astrocytoma - genetics | Glioblastoma - enzymology | Glioblastoma - genetics | Central Nervous System Neoplasms - genetics | Humans | Astrocytoma - enzymology | Central Nervous System Neoplasms - enzymology | Isocitrate Dehydrogenase - genetics | Mutation | Index Medicus
Journal Article